Early access

Ivermectin has no impact in treating mild COVID-19 in 400 adults in Columbia

6 March 2021. Related: Early access, COVID-19: investigational drugs, COVID-19.

No benefit from BRII and GSK monoclonal antibodies against COVID-19 in ACTIV-3 study

5 March 2021. Related: Early access, COVID-19: investigational drugs, COVID-19.

Chronic kidney disease (CKD) in HIV positive people linked to time with low CD4 count: partly reversible after effective ART

1 March 2021. Related: Early access, Side effects, OIs, coinfections and complications.